Stability and Feasibility of Dried Blood Spots for Hepatitis E Virus Serology in a Rural Setting.
DBS
HEV
IgG
dried blood spot
hepatitis E
serology
vaccine
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
15 11 2022
15 11 2022
Historique:
received:
30
09
2022
revised:
11
11
2022
accepted:
13
11
2022
entrez:
24
11
2022
pubmed:
25
11
2022
medline:
29
11
2022
Statut:
epublish
Résumé
Hepatitis E virus (HEV) is the most common cause of acute viral hepatitis worldwide. In many low-income countries it causes large outbreaks and disproportionally affects pregnant women and their offspring. Surveillance studies to find effective preventive interventions are needed but are hampered by the lack of funding and infrastructure. Dried blood spots (DBS) offer an easier and more robust way to collect, transport, and store blood samples compared to plasma/serum samples, and could ease some of the barriers for such studies. In this study we optimize an HEV IgG ELISA for DBS samples and validate it on 300 paired DBS and plasma samples collected in rural areas of Bangladesh from participants in a HEV vaccine study. We demonstrate that HEV IgG in blood stored as DBS is stable for two months at up to 40 °C, and for five freeze-thaw cycles. The specificity was 97% and the overall sensitivity of the DBS assay was 81%. The sensitivity was higher in samples from vaccinated participants (100%) compared to previously infected participants (59%), reflecting a positive correlation between IgG titer and sensitivity. We found a strong correlation between DBS and plasma samples with an r2 of 0.90, but with a higher degree of difference between individual paired samples. Our study shows that DBS offers a stable alternative to plasma/serum for HEV IgG measurements and can facilitate serological studies, particularly in resource limited areas.
Identifiants
pubmed: 36423134
pii: v14112525
doi: 10.3390/v14112525
pmc: PMC9692628
pii:
doi:
Substances chimiques
Hepatitis Antibodies
0
Immunoglobulin G
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
J Med Virol. 2017 Jun;89(6):1055-1061
pubmed: 27922197
Microbes Infect. 2022 Mar;24(2):104890
pubmed: 34628012
PLoS Negl Trop Dis. 2019 Jul 25;13(7):e0007453
pubmed: 31344038
Adv Exp Med Biol. 2016;948:223-246
pubmed: 27738988
BMJ Open. 2020 Jan 19;10(1):e033702
pubmed: 31959609
CMAJ. 2012 Jan 10;184(1):E70-6
pubmed: 22083674
PLoS One. 2021 Jul 22;16(7):e0255054
pubmed: 34293039
PLoS One. 2021 Mar 15;16(3):e0248218
pubmed: 33720928
J Med Virol. 2015 Sep;87(9):1491-9
pubmed: 25988945
Anal Biochem. 2005 Aug 1;343(1):54-65
pubmed: 15953581
Int J Neonatal Screen. 2015;1(2):69-78
pubmed: 28868497
Diagnostics (Basel). 2020 Apr 23;10(4):
pubmed: 32340321
Nat Rev Gastroenterol Hepatol. 2018 Feb;15(2):96-110
pubmed: 29162935
Bioanalysis. 2013 Aug;5(16):2023-41
pubmed: 23937137
J Med Virol. 2010 May;82(5):799-805
pubmed: 20336757
Ann Clin Biochem. 2021 Mar;58(2):123-131
pubmed: 33269949
PLoS One. 2022 Mar 24;17(3):e0265813
pubmed: 35324972
Theriogenology. 2010 Jun;73(9):1167-79
pubmed: 20138353